GSK, Vir Bio’s COVID-19 antibody treatment can reduce hospitalisation, deaths

They announced the results of the study, pending online publication, that demonstrates the efficacy of VIR-7831 against variants of concern from the UK, South Africa and Brazil.

from http://www.firstpost.com/health/gsk-vir-bios-covid-19-antibody-treatment-can-reduce-hospitalisation-deaths-9423321.html